Literature DB >> 6466553

Effects of soluble mediators generated during growth of the Landschütz ascites carcinoma on the chemotaxis of normal and Corynebacterium parvum-stimulated peritoneal leucocytes.

L C McIntosh, A W Thomson.   

Abstract

The influence of ascites fluid on the chemokinetic and chemotactic responses of mouse peritoneal leucocytes was investigated using modified Boyden chambers and the 'leading front' technique. The migration of normal cells towards endotoxin-activated mouse serum was significantly enhanced at high concentrations of fluid (40 and 20%) but was inhibited at lower concentrations (5 and 1%). By comparison, the chemotactic responsiveness of cells harvested 3 days after Corynebacterium parvum (C. parvum) injection was uniformly and more markedly increased over a wide range of fluid concentrations (0.1-50%). These effects were attributed to the presence of strong chemokinetic and chemotactic material in ascites fluid, which was not inactivated by heating. The activity was also demonstrated in the serum of tumour-bearing animals, was present to a much lesser extent in inflammatory exudate fluid and was absent from normal mouse serum. Detailed morphological studies of migrating cells revealed that although the ascites fluid contained a potent chemo-attractant for neutrophils, it inhibited the migration of mononuclear cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6466553      PMCID: PMC2040983     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  12 in total

1.  Inhibition of macrophage chemotaxis by neoplastic and other rapidly proliferating cells in vitro.

Authors:  S J Normann; E Sorkin
Journal:  Cancer Res       Date:  1977-03       Impact factor: 12.701

2.  Macrophage function in tumor-bearing mice: dissociation of phagocytic and chemotactic responsiveness.

Authors:  M S Meltzer; M M Stevenson
Journal:  Cell Immunol       Date:  1978-01       Impact factor: 4.868

3.  Characteristics of a low-molecular-weight factor extracted from mouse tumors that affects in vitro properties of macrophages.

Authors:  H T Cheung; W D Cantarow; G Sundharadas
Journal:  Int J Cancer       Date:  1979-03-15       Impact factor: 7.396

4.  Macrophages and resistance to tumours. I. Inhibition of delayed-type hypersensitivity reactions by tumour cells and by soluble prducts affecting macrophages.

Authors:  M Nelson; D S Nelson
Journal:  Immunology       Date:  1978-02       Impact factor: 7.397

5.  Characterization of macrophage chemotaxins in tumor cell cultures and comparison with lymphocyte-derived chemotactic factors.

Authors:  M S Meltzer; M M Stevenson; E J Leonard
Journal:  Cancer Res       Date:  1977-03       Impact factor: 12.701

6.  Lymphokine-like factors produced by human lymphoid cell lines with B or T cell surface markers.

Authors:  T Yoshida; T Kuratsuji; A Takada; Y Takada; J Minowada; S Cohen
Journal:  J Immunol       Date:  1976-08       Impact factor: 5.422

7.  Depression of macrophage function by a factor produced by neoplasms: a merchanism for abrogation of immune surveillance.

Authors:  M C Pike; R Snyderman
Journal:  J Immunol       Date:  1976-10       Impact factor: 5.422

8.  Depression of murine macrophage accumulation by low-molecular-weight derived from spontaneous mammary carcinomas.

Authors:  G J Cianciolo; R B Herberman; R Snyderman
Journal:  J Natl Cancer Inst       Date:  1980-10       Impact factor: 13.506

9.  Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor.

Authors:  S H Zigmond; J G Hirsch
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

10.  Inhibition by the Landschütz ascites carcinoma of the granulomatous inflammatory response to C. parvum.

Authors:  L C McIntosh; R G Pugh-Humphreys; R A Fraser; A W Thomson
Journal:  Br J Cancer       Date:  1982-04       Impact factor: 7.640

View more
  1 in total

1.  Influence of tumour carriage on the production of lymphokines affecting macrophage behaviour.

Authors:  L C McIntosh; L M Morrice; Y Udagawa; A W Thomson
Journal:  Immunology       Date:  1986-03       Impact factor: 7.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.